

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 8.82465571 |
| 2 | mannose metabolic process (GO:0006013) | 8.55134710 |
| 3 | lipoxygenase pathway (GO:0019372) | 8.10200225 |
| 4 | apoptotic cell clearance (GO:0043277) | 7.85886385 |
| 5 | opsonization (GO:0008228) | 7.26582031 |
| 6 | complement activation (GO:0006956) | 6.82778360 |
| 7 | regulation of complement activation (GO:0030449) | 6.54722436 |
| 8 | regulation of protein activation cascade (GO:2000257) | 6.17855719 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.11828193 |
| 10 | citrulline biosynthetic process (GO:0019240) | 5.90614359 |
| 11 | complement activation, classical pathway (GO:0006958) | 5.39818482 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 5.39277064 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.30505108 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30505108 |
| 15 | * regulation of integrin activation (GO:0033623) | 5.23857983 |
| 16 | regulation of macrophage chemotaxis (GO:0010758) | 5.16941718 |
| 17 | negative T cell selection (GO:0043383) | 5.09163040 |
| 18 | dendritic cell chemotaxis (GO:0002407) | 5.06523778 |
| 19 | protein activation cascade (GO:0072376) | 4.94350655 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.93662654 |
| 21 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.85544063 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77683530 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.75396257 |
| 24 | leukotriene metabolic process (GO:0006691) | 4.68288370 |
| 25 | T cell costimulation (GO:0031295) | 4.65513512 |
| 26 | negative regulation of granulocyte differentiation (GO:0030853) | 4.63022790 |
| 27 | lymphocyte costimulation (GO:0031294) | 4.58939735 |
| 28 | activated T cell proliferation (GO:0050798) | 4.54206419 |
| 29 | positive regulation of neutrophil migration (GO:1902624) | 4.51832432 |
| 30 | positive regulation of neutrophil chemotaxis (GO:0090023) | 4.51832432 |
| 31 | regulation of cellular extravasation (GO:0002691) | 4.48804761 |
| 32 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.48272361 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.45693078 |
| 34 | NIK/NF-kappaB signaling (GO:0038061) | 4.44550779 |
| 35 | response to interleukin-15 (GO:0070672) | 4.43519826 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 4.40833947 |
| 37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.38343309 |
| 38 | regulation of regulatory T cell differentiation (GO:0045589) | 4.37407668 |
| 39 | positive regulation of pseudopodium assembly (GO:0031274) | 4.34166373 |
| 40 | positive thymic T cell selection (GO:0045059) | 4.32895534 |
| 41 | thymic T cell selection (GO:0045061) | 4.32691564 |
| 42 | * regulation of humoral immune response (GO:0002920) | 4.26632602 |
| 43 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.25946439 |
| 44 | fatty acid derivative biosynthetic process (GO:1901570) | 4.23862806 |
| 45 | icosanoid biosynthetic process (GO:0046456) | 4.23862806 |
| 46 | response to prostaglandin E (GO:0034695) | 4.21467395 |
| 47 | cellular extravasation (GO:0045123) | 4.19689511 |
| 48 | regulation of T cell tolerance induction (GO:0002664) | 4.19491998 |
| 49 | positive regulation of granulocyte chemotaxis (GO:0071624) | 4.19281433 |
| 50 | positive regulation of respiratory burst (GO:0060267) | 4.18818571 |
| 51 | T cell selection (GO:0045058) | 4.16436287 |
| 52 | regulation of phagocytosis (GO:0050764) | 4.14801906 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.14401043 |
| 54 | myeloid dendritic cell differentiation (GO:0043011) | 4.08429080 |
| 55 | response to type I interferon (GO:0034340) | 4.01849342 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.99088726 |
| 57 | dendritic cell migration (GO:0036336) | 3.98476178 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.97471160 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.97471160 |
| 60 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.94280427 |
| 61 | positive T cell selection (GO:0043368) | 3.93161675 |
| 62 | cellular response to interleukin-15 (GO:0071350) | 3.92314865 |
| 63 | regulation of pseudopodium assembly (GO:0031272) | 3.88816858 |
| 64 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.82480034 |
| 65 | protein carboxylation (GO:0018214) | 3.82480034 |
| 66 | cyclooxygenase pathway (GO:0019371) | 3.82234903 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.81818647 |
| 68 | leukocyte tethering or rolling (GO:0050901) | 3.78438288 |
| 69 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.78042352 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 3.76281109 |
| 71 | citrulline metabolic process (GO:0000052) | 3.72748928 |
| 72 | tolerance induction (GO:0002507) | 3.71120585 |
| 73 | detection of external biotic stimulus (GO:0098581) | 3.67451851 |
| 74 | cytokine production involved in immune response (GO:0002367) | 3.67091220 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64736639 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 3.62246343 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 3.61137294 |
| 78 | unsaturated fatty acid biosynthetic process (GO:0006636) | 3.59944404 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 3.56604837 |
| 80 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.55671543 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 3.52770736 |
| 82 | positive regulation of hemostasis (GO:1900048) | 3.52770736 |
| 83 | arachidonic acid metabolic process (GO:0019369) | 3.49105168 |
| 84 | detection of biotic stimulus (GO:0009595) | 3.47825249 |
| 85 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.46904432 |
| 86 | response to nitric oxide (GO:0071731) | 3.41487823 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.41289073 |
| 88 | regulation of mononuclear cell migration (GO:0071675) | 3.39440334 |
| 89 | respiratory burst (GO:0045730) | 3.37162032 |
| 90 | positive regulation of coagulation (GO:0050820) | 3.35312144 |
| 91 | regulation of respiratory burst (GO:0060263) | 3.33605966 |
| 92 | detection of bacterium (GO:0016045) | 3.33408017 |
| 93 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.30338748 |
| 94 | prostaglandin biosynthetic process (GO:0001516) | 3.29543124 |
| 95 | prostanoid biosynthetic process (GO:0046457) | 3.29543124 |
| 96 | positive regulation of phagocytosis (GO:0050766) | 3.29381329 |
| 97 | T cell mediated immunity (GO:0002456) | 3.29129460 |
| 98 | dendritic cell differentiation (GO:0097028) | 3.25490335 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.24083206 |
| 100 | oxygen transport (GO:0015671) | 3.23807424 |
| 101 | production of molecular mediator of immune response (GO:0002440) | 3.23148375 |
| 102 | positive regulation of cholesterol efflux (GO:0010875) | 3.22106253 |
| 103 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.20998913 |
| 104 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.19957742 |
| 105 | regulation of neutrophil migration (GO:1902622) | 3.19901045 |
| 106 | regulation of neutrophil chemotaxis (GO:0090022) | 3.19901045 |
| 107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19809036 |
| 108 | regulation of antigen processing and presentation (GO:0002577) | 3.19226193 |
| 109 | regulation of cholesterol storage (GO:0010885) | 3.18490730 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 3.18311211 |
| 111 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.18306056 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 3.17264140 |
| 113 | glomerular filtration (GO:0003094) | 3.16264907 |
| 114 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.16251340 |
| 115 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.13755917 |
| 116 | response to prostaglandin (GO:0034694) | 3.13707212 |
| 117 | phagocytosis (GO:0006909) | 3.12923627 |
| 118 | cellular response to interferon-gamma (GO:0071346) | 3.11193715 |
| 119 | detection of other organism (GO:0098543) | 3.11165046 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09942203 |
| 121 | negative regulation of interleukin-6 production (GO:0032715) | 3.08913469 |
| 122 | positive regulation of B cell differentiation (GO:0045579) | 3.06975134 |
| 123 | * positive regulation of lymphocyte migration (GO:2000403) | 3.06685602 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05961528 |
| 125 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05099315 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02429508 |
| 127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00914717 |
| 128 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.00313050 |
| 129 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98804256 |
| 130 | humoral immune response (GO:0006959) | 2.97506195 |
| 131 | B cell mediated immunity (GO:0019724) | 2.97221772 |
| 132 | phospholipid efflux (GO:0033700) | 2.95888300 |
| 133 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.95879817 |
| 134 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.95879817 |
| 135 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.95079182 |
| 136 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95079182 |
| 137 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94638997 |
| 138 | positive regulation of sterol transport (GO:0032373) | 2.94559747 |
| 139 | positive regulation of cholesterol transport (GO:0032376) | 2.94559747 |
| 140 | cGMP-mediated signaling (GO:0019934) | 2.94397804 |
| 141 | response to interferon-gamma (GO:0034341) | 2.94229801 |
| 142 | negative regulation of interleukin-2 production (GO:0032703) | 2.93881222 |
| 143 | positive regulation of immunoglobulin production (GO:0002639) | 2.93258448 |
| 144 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92493495 |
| 145 | regulation of granulocyte chemotaxis (GO:0071622) | 2.92360891 |
| 146 | leukocyte cell-cell adhesion (GO:0007159) | 2.90472883 |
| 147 | adaptation of signaling pathway (GO:0023058) | 2.89242977 |
| 148 | antimicrobial humoral response (GO:0019730) | 2.87533432 |
| 149 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.86987380 |
| 150 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.86987380 |
| 151 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.86987380 |
| 152 | prostanoid metabolic process (GO:0006692) | 2.86953081 |
| 153 | prostaglandin metabolic process (GO:0006693) | 2.86953081 |
| 154 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.85562907 |
| 155 | B cell proliferation (GO:0042100) | 2.85458701 |
| 156 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.85382320 |
| 157 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.85311268 |
| 158 | plasma lipoprotein particle clearance (GO:0034381) | 2.83971476 |
| 159 | leukocyte aggregation (GO:0070486) | 2.83739083 |
| 160 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83053149 |
| 161 | response to interferon-beta (GO:0035456) | 2.82216021 |
| 162 | regulation of B cell differentiation (GO:0045577) | 2.81572624 |
| 163 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.81105883 |
| 164 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.79326438 |
| 165 | * positive regulation of T cell migration (GO:2000406) | 2.79128018 |
| 166 | angiotensin maturation (GO:0002003) | 2.78713614 |
| 167 | negative regulation of macrophage differentiation (GO:0045650) | 2.78036571 |
| 168 | regulation of macrophage cytokine production (GO:0010935) | 2.71690699 |
| 169 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.70570717 |
| 170 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.70135503 |
| 171 | low-density lipoprotein particle clearance (GO:0034383) | 2.69228108 |
| 172 | cellular response to interleukin-6 (GO:0071354) | 2.67511735 |
| 173 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66385317 |
| 174 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66385317 |
| 175 | modulation by symbiont of host immune response (GO:0052553) | 2.66385317 |
| 176 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66385317 |
| 177 | modulation by symbiont of host defense response (GO:0052031) | 2.66385317 |
| 178 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66385317 |
| 179 | urea metabolic process (GO:0019627) | 2.63690129 |
| 180 | urea cycle (GO:0000050) | 2.63690129 |
| 181 | leukotriene biosynthetic process (GO:0019370) | 2.63637148 |
| 182 | fatty acid derivative metabolic process (GO:1901568) | 2.61131505 |
| 183 | icosanoid metabolic process (GO:0006690) | 2.61131505 |
| 184 | acute-phase response (GO:0006953) | 2.59692224 |
| 185 | regulation of apoptotic cell clearance (GO:2000425) | 12.8985731 |
| 186 | complement activation, alternative pathway (GO:0006957) | 10.4486093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.14264198 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.03558573 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.93079976 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.89195740 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.99439608 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.94412735 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91303536 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86001296 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83031819 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56993874 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.56673409 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.53355486 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49971722 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42364352 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.18399486 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18350053 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18042469 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10213747 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06436695 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03562896 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02510962 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00432158 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.95846131 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90415200 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87331804 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84309699 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84292453 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74103820 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.72586009 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.70687699 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66778821 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66071232 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60016240 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56344994 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55335774 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54159065 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50774985 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.50672114 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50148666 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49676487 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.49469256 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47573971 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46603312 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46351588 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45706937 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44472954 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44185342 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42151952 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41268934 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39506269 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37100304 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36051837 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35343611 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34587604 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31358302 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30954100 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29170688 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28010380 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27959411 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24385219 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24207638 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23871164 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23048566 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22572838 |
| 65 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.19077993 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14632128 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14099578 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13625827 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13257154 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13091561 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11723588 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10040191 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09778084 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09602413 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09393541 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08529873 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06960154 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06890695 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05856024 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04670952 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04123911 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03824123 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03410272 |
| 84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.03196821 |
| 85 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02763910 |
| 86 | MAF_26560356_Chip-Seq_TH1_Human | 1.02396665 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01174683 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00714015 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00525184 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99953926 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99926055 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98605508 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97084019 |
| 94 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96291105 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95575487 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94593104 |
| 97 | MYC_22102868_ChIP-Seq_BL_Human | 0.94205025 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94099535 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93669681 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93429482 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92290478 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91071969 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90945401 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90376610 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90253097 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90149852 |
| 107 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89070603 |
| 108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88967562 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88652942 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88431251 |
| 111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88145474 |
| 112 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87963528 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86754012 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86648846 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86353769 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85267100 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.84797279 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.84643807 |
| 119 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.84487882 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84394886 |
| 121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83174539 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.82997085 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82943130 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82850251 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82486314 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81035367 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78232590 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76734287 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74384902 |
| 130 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73756607 |
| 131 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72978736 |
| 132 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.71201053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.87494290 |
| 2 | MP0009840_abnormal_foam_cell | 3.69353707 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.61434437 |
| 4 | MP0003724_increased_susceptibility_to | 3.56016505 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.53403345 |
| 6 | MP0003436_decreased_susceptibility_to | 3.39709607 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.29579229 |
| 8 | MP0001790_abnormal_immune_system | 3.04175860 |
| 9 | MP0005387_immune_system_phenotype | 3.04175860 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 3.03910731 |
| 11 | MP0000685_abnormal_immune_system | 2.97895950 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.87698869 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.77764048 |
| 14 | MP0003303_peritoneal_inflammation | 2.65046751 |
| 15 | MP0003075_altered_response_to | 2.59561819 |
| 16 | MP0005025_abnormal_response_to | 2.51277032 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.45808097 |
| 18 | MP0002419_abnormal_innate_immunity | 2.45750235 |
| 19 | MP0002254_reproductive_system_inflammat | 2.41628056 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.34383140 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.32160962 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.23517351 |
| 23 | MP0004947_skin_inflammation | 2.19119844 |
| 24 | MP0003866_abnormal_defecation | 2.17893136 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.15546709 |
| 26 | MP0001851_eye_inflammation | 2.07855671 |
| 27 | MP0001835_abnormal_antigen_presentation | 2.07318704 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.89485820 |
| 29 | MP0001853_heart_inflammation | 1.88702144 |
| 30 | MP0001800_abnormal_humoral_immune | 1.82100922 |
| 31 | MP0000604_amyloidosis | 1.81379810 |
| 32 | MP0004510_myositis | 1.75016324 |
| 33 | MP0008004_abnormal_stomach_pH | 1.62605994 |
| 34 | MP0005023_abnormal_wound_healing | 1.59965999 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.57160739 |
| 36 | * MP0002452_abnormal_antigen_presenting | 1.56401395 |
| 37 | MP0010352_gastrointestinal_tract_polyps | 1.55736921 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.54502261 |
| 39 | MP0002405_respiratory_system_inflammati | 1.53851156 |
| 40 | MP0000767_abnormal_smooth_muscle | 1.49906841 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.48200701 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.48144408 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.45424691 |
| 44 | MP0009763_increased_sensitivity_to | 1.43329441 |
| 45 | MP0005360_urolithiasis | 1.43191055 |
| 46 | MP0000249_abnormal_blood_vessel | 1.40221907 |
| 47 | MP0009785_altered_susceptibility_to | 1.39534420 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.39196930 |
| 49 | MP0001849_ear_inflammation | 1.38252871 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.37290119 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.35303243 |
| 52 | MP0004272_abnormal_basement_membrane | 1.33312498 |
| 53 | * MP0002420_abnormal_adaptive_immunity | 1.32720585 |
| 54 | * MP0001819_abnormal_immune_cell | 1.30635231 |
| 55 | MP0002933_joint_inflammation | 1.29611011 |
| 56 | MP0002723_abnormal_immune_serum | 1.29023145 |
| 57 | MP0004885_abnormal_endolymph | 1.27511543 |
| 58 | MP0005390_skeleton_phenotype | 1.23767592 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.23637639 |
| 60 | MP0000343_altered_response_to | 1.23362060 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.22964825 |
| 62 | MP0005451_abnormal_body_composition | 1.22432777 |
| 63 | MP0005166_decreased_susceptibility_to | 1.20022518 |
| 64 | MP0003690_abnormal_glial_cell | 1.18012216 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.16306836 |
| 66 | MP0008469_abnormal_protein_level | 1.16087579 |
| 67 | MP0003878_abnormal_ear_physiology | 1.12942142 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.12942142 |
| 69 | MP0006082_CNS_inflammation | 1.12011706 |
| 70 | MP0002168_other_aberrant_phenotype | 1.11970278 |
| 71 | MP0001663_abnormal_digestive_system | 1.10999113 |
| 72 | MP0009764_decreased_sensitivity_to | 1.09551309 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.07824801 |
| 74 | MP0005670_abnormal_white_adipose | 1.07250699 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06314985 |
| 76 | MP0005332_abnormal_amino_acid | 1.05345745 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.04485926 |
| 78 | MP0005365_abnormal_bile_salt | 1.03914161 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.03047740 |
| 80 | * MP0000716_abnormal_immune_system | 1.02426270 |
| 81 | MP0002136_abnormal_kidney_physiology | 1.02420630 |
| 82 | MP0001915_intracranial_hemorrhage | 1.00526494 |
| 83 | MP0000609_abnormal_liver_physiology | 0.98354472 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.98224350 |
| 85 | MP0003638_abnormal_response/metabolism_ | 0.97565854 |
| 86 | MP0000490_abnormal_crypts_of | 0.96613717 |
| 87 | MP0003448_altered_tumor_morphology | 0.93885575 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.93561835 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 0.92589853 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.90988955 |
| 91 | MP0001873_stomach_inflammation | 0.90948725 |
| 92 | MP0002006_tumorigenesis | 0.90443686 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.89876592 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 0.89802507 |
| 95 | * MP0000689_abnormal_spleen_morphology | 0.89686526 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.86825013 |
| 97 | MP0000858_altered_metastatic_potential | 0.86075166 |
| 98 | MP0002282_abnormal_trachea_morphology | 0.85644473 |
| 99 | MP0009643_abnormal_urine_homeostasis | 0.83612029 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.83592943 |
| 101 | MP0005085_abnormal_gallbladder_physiolo | 0.82713960 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.82542012 |
| 103 | MP0002429_abnormal_blood_cell | 0.82140912 |
| 104 | MP0002135_abnormal_kidney_morphology | 0.79743075 |
| 105 | MP0003329_amyloid_beta_deposits | 0.79551214 |
| 106 | MP0005310_abnormal_salivary_gland | 0.79334045 |
| 107 | MP0003045_fibrosis | 0.78287592 |
| 108 | MP0002971_abnormal_brown_adipose | 0.77968314 |
| 109 | MP0003868_abnormal_feces_composition | 0.76758965 |
| 110 | MP0009278_abnormal_bone_marrow | 0.75020628 |
| 111 | MP0003091_abnormal_cell_migration | 0.74132079 |
| 112 | MP0001614_abnormal_blood_vessel | 0.74063971 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.73750593 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73412243 |
| 115 | MP0002060_abnormal_skin_morphology | 0.73244841 |
| 116 | MP0002398_abnormal_bone_marrow | 0.72963002 |
| 117 | MP0005165_increased_susceptibility_to | 0.72808406 |
| 118 | * MP0002722_abnormal_immune_system | 0.70872824 |
| 119 | MP0000598_abnormal_liver_morphology | 0.69378797 |
| 120 | MP0005083_abnormal_biliary_tract | 0.68993953 |
| 121 | MP0004019_abnormal_vitamin_homeostasis | 0.68455982 |
| 122 | MP0010234_abnormal_vibrissa_follicle | 0.68081966 |
| 123 | MP0002796_impaired_skin_barrier | 0.64495122 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.63972816 |
| 125 | MP0003252_abnormal_bile_duct | 0.62625793 |
| 126 | MP0003279_aneurysm | 0.61162055 |
| 127 | MP0009379_abnormal_foot_pigmentation | 0.58520044 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.58098737 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.55009824 |
| 130 | MP0002693_abnormal_pancreas_physiology | 0.52684839 |
| 131 | MP0005275_abnormal_skin_tensile | 0.50167256 |
| 132 | MP0003795_abnormal_bone_structure | 0.50085776 |
| 133 | MP0002009_preneoplasia | 0.48471279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glomerulonephritis (HP:0000099) | 8.08630024 |
| 2 | Complement deficiency (HP:0004431) | 7.65096535 |
| 3 | Abnormality of complement system (HP:0005339) | 7.62977478 |
| 4 | Chronic diarrhea (HP:0002028) | 6.24133474 |
| 5 | Gastrointestinal stroma tumor (HP:0100723) | 6.04287554 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.42911901 |
| 7 | Dysostosis multiplex (HP:0000943) | 5.04235576 |
| 8 | Vasculitis (HP:0002633) | 4.86763244 |
| 9 | Shallow orbits (HP:0000586) | 4.83797380 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.79516698 |
| 11 | Nephritis (HP:0000123) | 4.73897649 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.72744575 |
| 13 | Spondylolisthesis (HP:0003302) | 4.60420016 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.57987728 |
| 15 | Deep venous thrombosis (HP:0002625) | 4.39193283 |
| 16 | Emphysema (HP:0002097) | 4.37633770 |
| 17 | Nasal polyposis (HP:0100582) | 4.23133212 |
| 18 | IgA deficiency (HP:0002720) | 4.18096358 |
| 19 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.10678933 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.06965417 |
| 21 | Agammaglobulinemia (HP:0004432) | 4.02736018 |
| 22 | Mucopolysacchariduria (HP:0008155) | 4.00576257 |
| 23 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.00576257 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 3.94994314 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.93553984 |
| 26 | Cervical subluxation (HP:0003308) | 3.91427799 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.90432183 |
| 28 | Lymphopenia (HP:0001888) | 3.90318617 |
| 29 | Abnormality of the prostate (HP:0008775) | 3.86995667 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.86560858 |
| 31 | Meningitis (HP:0001287) | 3.82759011 |
| 32 | Pustule (HP:0200039) | 3.77852358 |
| 33 | Malnutrition (HP:0004395) | 3.74730988 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.72424423 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.72424423 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.72424423 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 3.67056118 |
| 38 | Wrist flexion contracture (HP:0001239) | 3.63935174 |
| 39 | Loss of speech (HP:0002371) | 3.62123415 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57861388 |
| 41 | Peritonitis (HP:0002586) | 3.53064934 |
| 42 | Abnormality of T cell number (HP:0011839) | 3.48051087 |
| 43 | J-shaped sella turcica (HP:0002680) | 3.47819432 |
| 44 | T lymphocytopenia (HP:0005403) | 3.47493926 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 3.37562105 |
| 46 | Abnormality of T cells (HP:0002843) | 3.36511225 |
| 47 | Obstructive lung disease (HP:0006536) | 3.36195761 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 3.36195761 |
| 49 | Joint stiffness (HP:0001387) | 3.32706335 |
| 50 | Cerebral aneurysm (HP:0004944) | 3.32051919 |
| 51 | Recurrent viral infections (HP:0004429) | 3.30590691 |
| 52 | Hemoptysis (HP:0002105) | 3.24883411 |
| 53 | Recurrent sinusitis (HP:0011108) | 3.21909143 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 3.20223503 |
| 55 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14683632 |
| 56 | Menorrhagia (HP:0000132) | 3.09761041 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 3.08922413 |
| 58 | Arthropathy (HP:0003040) | 3.07236582 |
| 59 | Bronchomalacia (HP:0002780) | 3.05413401 |
| 60 | Myositis (HP:0100614) | 3.04632342 |
| 61 | Increased IgE level (HP:0003212) | 2.98459110 |
| 62 | Autoimmune hemolytic anemia (HP:0001890) | 2.97235777 |
| 63 | Abnormality of B cell number (HP:0010975) | 2.95433353 |
| 64 | IgG deficiency (HP:0004315) | 2.95423060 |
| 65 | Chronic otitis media (HP:0000389) | 2.93422548 |
| 66 | Colitis (HP:0002583) | 2.92626913 |
| 67 | B lymphocytopenia (HP:0010976) | 2.88569034 |
| 68 | IgM deficiency (HP:0002850) | 2.86608617 |
| 69 | Increased IgM level (HP:0003496) | 2.84768084 |
| 70 | Prostate neoplasm (HP:0100787) | 2.81903734 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.78971116 |
| 72 | Pulmonary embolism (HP:0002204) | 2.78124411 |
| 73 | Encephalitis (HP:0002383) | 2.75969196 |
| 74 | Arterial tortuosity (HP:0005116) | 2.75761586 |
| 75 | Chest pain (HP:0100749) | 2.73036302 |
| 76 | Short nail (HP:0001799) | 2.72809970 |
| 77 | Abnormality of the lumbar spine (HP:0100712) | 2.71574731 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.71273173 |
| 79 | Orchitis (HP:0100796) | 2.67022310 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.66121593 |
| 81 | Gangrene (HP:0100758) | 2.64071581 |
| 82 | Bronchitis (HP:0012387) | 2.63849812 |
| 83 | Skin rash (HP:0000988) | 2.61926377 |
| 84 | Abnormality of macrophages (HP:0004311) | 2.61006541 |
| 85 | Broad metatarsal (HP:0001783) | 2.60303275 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 2.59659783 |
| 87 | Optic neuritis (HP:0100653) | 2.59659783 |
| 88 | Deformed sella turcica (HP:0002681) | 2.56878834 |
| 89 | Esophageal varix (HP:0002040) | 2.53412085 |
| 90 | Joint hemorrhage (HP:0005261) | 2.48984513 |
| 91 | Joint swelling (HP:0001386) | 2.46679121 |
| 92 | Thoracic kyphosis (HP:0002942) | 2.46603926 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.46426801 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.45495250 |
| 95 | Gingivitis (HP:0000230) | 2.45277317 |
| 96 | Lymphoma (HP:0002665) | 2.42948394 |
| 97 | Vascular tortuosity (HP:0004948) | 2.42212810 |
| 98 | Hand muscle atrophy (HP:0009130) | 2.38321411 |
| 99 | Prolonged bleeding time (HP:0003010) | 2.37893493 |
| 100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.36837408 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.36483286 |
| 102 | Enlarged penis (HP:0000040) | 2.36337759 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.32790953 |
| 104 | Periodontitis (HP:0000704) | 2.31531436 |
| 105 | Arthralgia (HP:0002829) | 2.29838697 |
| 106 | Verrucae (HP:0200043) | 2.29672315 |
| 107 | Papilloma (HP:0012740) | 2.29672315 |
| 108 | Polygenic inheritance (HP:0010982) | 2.28634091 |
| 109 | Ileus (HP:0002595) | 2.28529987 |
| 110 | Stomatitis (HP:0010280) | 2.28475262 |
| 111 | Abnormality of the pleura (HP:0002103) | 2.26118569 |
| 112 | Abnormality of the fingertips (HP:0001211) | 2.24462355 |
| 113 | Multifactorial inheritance (HP:0001426) | 2.22093373 |
| 114 | Abnormality of male internal genitalia (HP:0000022) | 2.18878034 |
| 115 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.18106894 |
| 116 | Villous atrophy (HP:0011473) | 2.18106894 |
| 117 | Glomerulopathy (HP:0100820) | 2.15939688 |
| 118 | Toxemia of pregnancy (HP:0100603) | 2.15751372 |
| 119 | Leukocytosis (HP:0001974) | 2.13537894 |
| 120 | Beaking of vertebral bodies (HP:0004568) | 2.12070378 |
| 121 | Turricephaly (HP:0000262) | 2.11757813 |
| 122 | Recurrent skin infections (HP:0001581) | 2.11165589 |
| 123 | Osteomyelitis (HP:0002754) | 2.10127602 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 2.09994677 |
| 125 | Congenital malformation of the right heart (HP:0011723) | 2.08554452 |
| 126 | Double outlet right ventricle (HP:0001719) | 2.08554452 |
| 127 | Neurofibrillary tangles (HP:0002185) | 2.08475154 |
| 128 | Ureteral stenosis (HP:0000071) | 2.07048884 |
| 129 | Severe combined immunodeficiency (HP:0004430) | 2.06514328 |
| 130 | Hematochezia (HP:0002573) | 2.05545668 |
| 131 | Systemic lupus erythematosus (HP:0002725) | 11.8635193 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.98467483 |
| 133 | Coarse hair (HP:0002208) | 1.96562341 |
| 134 | Keratoconjunctivitis sicca (HP:0001097) | 1.96457798 |
| 135 | Chronic sinusitis (HP:0011109) | 1.96455293 |
| 136 | Cellulitis (HP:0100658) | 1.95807697 |
| 137 | Mitral stenosis (HP:0001718) | 1.94701491 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.94058770 |
| 139 | Epistaxis (HP:0000421) | 1.93827585 |
| 140 | Flat acetabular roof (HP:0003180) | 1.93408221 |
| 141 | Skin ulcer (HP:0200042) | 1.93136782 |
| 142 | Urticaria (HP:0001025) | 1.92000289 |
| 143 | Upper limb amyotrophy (HP:0009129) | 1.91534313 |
| 144 | Distal upper limb amyotrophy (HP:0007149) | 1.91534313 |
| 145 | Pulmonary fibrosis (HP:0002206) | 1.89927859 |
| 146 | Eosinophilia (HP:0001880) | 1.89102761 |
| 147 | Neonatal hypoglycemia (HP:0001998) | 1.89006719 |
| 148 | Granulocytopenia (HP:0001913) | 1.88755640 |
| 149 | Xanthomatosis (HP:0000991) | 1.85551017 |
| 150 | Mediastinal lymphadenopathy (HP:0100721) | 1.81118540 |
| 151 | Facial diplegia (HP:0001349) | 1.78468711 |
| 152 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.76903256 |
| 153 | Broad face (HP:0000283) | 1.75094423 |
| 154 | Thickened calvaria (HP:0002684) | 1.73602879 |
| 155 | Abnormality of the sella turcica (HP:0002679) | 1.72668683 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 1.72153826 |
| 157 | Abnormality of the thoracic spine (HP:0100711) | 1.71105467 |
| 158 | Hypoplasia of the odontoid process (HP:0003311) | 1.68722818 |
| 159 | Purpura (HP:0000979) | 1.63502457 |
| 160 | Gingival bleeding (HP:0000225) | 1.61511642 |
| 161 | Pathologic fracture (HP:0002756) | 1.59541639 |
| 162 | Amyloidosis (HP:0011034) | 1.58532294 |
| 163 | Osteolytic defects of the hand bones (HP:0009699) | 1.58087557 |
| 164 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.58087557 |
| 165 | Ulnar deviation of the wrist (HP:0003049) | 1.57824341 |
| 166 | Disinhibition (HP:0000734) | 1.56559485 |
| 167 | Severe short stature (HP:0003510) | 1.56511418 |
| 168 | Recurrent cutaneous fungal infections (HP:0011370) | 1.55851986 |
| 169 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.55851986 |
| 170 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.54935983 |
| 171 | Vertebral hypoplasia (HP:0008417) | 1.54935983 |
| 172 | Restrictive lung disease (HP:0002091) | 1.54334986 |
| 173 | Synostosis involving the elbow (HP:0003938) | 1.53593826 |
| 174 | Humeroradial synostosis (HP:0003041) | 1.53593826 |
| 175 | Aortic dissection (HP:0002647) | 1.51893524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 7.57106588 |
| 2 | TXK | 5.14132332 |
| 3 | ERN1 | 3.95873895 |
| 4 | MET | 3.33809556 |
| 5 | CAMK1D | 3.33667261 |
| 6 | TRIB3 | 3.01415561 |
| 7 | DAPK2 | 2.98530555 |
| 8 | BLK | 2.96810862 |
| 9 | PRPF4B | 2.92288045 |
| 10 | MAP4K1 | 2.58576149 |
| 11 | CAMK1G | 2.55183461 |
| 12 | EPHB1 | 2.42733025 |
| 13 | RIPK1 | 2.40842589 |
| 14 | TESK1 | 2.38041043 |
| 15 | TAOK3 | 2.36886940 |
| 16 | TYK2 | 2.02731173 |
| 17 | BMX | 2.01684365 |
| 18 | TGFBR2 | 1.90011302 |
| 19 | ITK | 1.77202088 |
| 20 | PTK6 | 1.74517579 |
| 21 | PKN2 | 1.71596412 |
| 22 | PASK | 1.69306309 |
| 23 | TNK2 | 1.57467463 |
| 24 | SMG1 | 1.55149890 |
| 25 | EPHA3 | 1.43518478 |
| 26 | EPHB2 | 1.42314910 |
| 27 | MAP3K11 | 1.40414527 |
| 28 | FES | 1.39136051 |
| 29 | LRRK2 | 1.32925150 |
| 30 | ZAP70 | 1.32679667 |
| 31 | GRK6 | 1.30958985 |
| 32 | MAP3K13 | 1.30639193 |
| 33 | TTN | 1.29227198 |
| 34 | IRAK4 | 1.28877636 |
| 35 | BMPR2 | 1.27505393 |
| 36 | HCK | 1.23675648 |
| 37 | PRKCH | 1.21953489 |
| 38 | STK10 | 1.21084990 |
| 39 | TBK1 | 1.18653562 |
| 40 | FGR | 1.16621748 |
| 41 | CSK | 1.14926107 |
| 42 | HIPK2 | 1.13937609 |
| 43 | FGFR4 | 1.13813560 |
| 44 | MAP2K3 | 1.06577565 |
| 45 | MST4 | 1.04869634 |
| 46 | KIT | 1.00332863 |
| 47 | SIK3 | 0.98838854 |
| 48 | MAP3K14 | 0.97657239 |
| 49 | JAK3 | 0.93766167 |
| 50 | JAK1 | 0.92566519 |
| 51 | DAPK1 | 0.92245681 |
| 52 | PRKCQ | 0.91669171 |
| 53 | ACVR1B | 0.91605610 |
| 54 | CAMKK2 | 0.90359177 |
| 55 | CAMKK1 | 0.89304222 |
| 56 | CDC42BPA | 0.87539182 |
| 57 | IRAK1 | 0.85998851 |
| 58 | NTRK1 | 0.85485497 |
| 59 | CLK1 | 0.83197466 |
| 60 | IGF1R | 0.79363272 |
| 61 | BTK | 0.78607279 |
| 62 | MAP3K7 | 0.76759786 |
| 63 | EPHA2 | 0.76201080 |
| 64 | MAPK11 | 0.75716337 |
| 65 | SIK2 | 0.73284169 |
| 66 | EEF2K | 0.71581425 |
| 67 | JAK2 | 0.69683743 |
| 68 | RIPK4 | 0.69540156 |
| 69 | NLK | 0.68982007 |
| 70 | DAPK3 | 0.66124688 |
| 71 | IKBKE | 0.64941687 |
| 72 | FER | 0.64857829 |
| 73 | MAP3K1 | 0.63674470 |
| 74 | RPS6KA4 | 0.62810983 |
| 75 | STK38 | 0.62289101 |
| 76 | MAP3K6 | 0.60964462 |
| 77 | SYK | 0.60604879 |
| 78 | LCK | 0.58739821 |
| 79 | PDGFRB | 0.58567529 |
| 80 | EGFR | 0.56831092 |
| 81 | CSF1R | 0.56241408 |
| 82 | RPS6KA2 | 0.55123488 |
| 83 | MARK3 | 0.53626156 |
| 84 | MAPK12 | 0.53420626 |
| 85 | MAPK7 | 0.53131998 |
| 86 | TEC | 0.51934911 |
| 87 | KDR | 0.51160745 |
| 88 | CHUK | 0.50919339 |
| 89 | PRKAA2 | 0.50587600 |
| 90 | FYN | 0.48367904 |
| 91 | GRK7 | 0.48094550 |
| 92 | PTK2 | 0.48072165 |
| 93 | MAP3K3 | 0.46502969 |
| 94 | PDPK1 | 0.46371674 |
| 95 | FGFR1 | 0.45586550 |
| 96 | MATK | 0.45286673 |
| 97 | PRKG2 | 0.43764993 |
| 98 | FGFR3 | 0.43086033 |
| 99 | DMPK | 0.42801769 |
| 100 | TYRO3 | 0.42091305 |
| 101 | FLT3 | 0.41050175 |
| 102 | MELK | 0.40071302 |
| 103 | GRK5 | 0.39924992 |
| 104 | TGFBR1 | 0.39736302 |
| 105 | SIK1 | 0.39421574 |
| 106 | IKBKB | 0.39088766 |
| 107 | PIM1 | 0.37460833 |
| 108 | RPS6KL1 | 0.36936727 |
| 109 | RPS6KC1 | 0.36936727 |
| 110 | RPS6KA6 | 0.36929706 |
| 111 | MAP2K4 | 0.36374218 |
| 112 | SCYL2 | 0.33313505 |
| 113 | INSR | 0.33230723 |
| 114 | PTK2B | 0.32483238 |
| 115 | CAMK1 | 0.31592654 |
| 116 | NEK9 | 0.31107698 |
| 117 | TAOK1 | 0.30134634 |
| 118 | MAP2K2 | 0.29964694 |
| 119 | MAP3K10 | 0.29930921 |
| 120 | RET | 0.29450448 |
| 121 | ALK | 0.29280210 |
| 122 | PRKCD | 0.29032086 |
| 123 | PKN1 | 0.28064848 |
| 124 | INSRR | 0.27572296 |
| 125 | MYLK | 0.26878873 |
| 126 | MAPK3 | 0.26759348 |
| 127 | MAPKAPK2 | 0.26160053 |
| 128 | TAOK2 | 0.25306061 |
| 129 | PIK3CG | 0.25020930 |
| 130 | MAPK4 | 0.24376490 |
| 131 | DDR2 | 0.24176145 |
| 132 | PDGFRA | 0.23515249 |
| 133 | PDK1 | 0.23403735 |
| 134 | BCR | 0.22485387 |
| 135 | LYN | 0.21443409 |
| 136 | MAPKAPK3 | 0.21069840 |
| 137 | SRC | 0.20171670 |
| 138 | CDK9 | 0.19979136 |
| 139 | ILK | 0.19252110 |
| 140 | STK11 | 0.18680515 |
| 141 | TRPM7 | 0.17874551 |
| 142 | CDK4 | 0.17617987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 8.10597435 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 5.51430350 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.86802556 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.33898952 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.32950801 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 4.22489180 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.76661799 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.54758294 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.37281788 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.24580537 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 3.07932019 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.84522161 |
| 13 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.15060773 |
| 14 | Prion diseases_Homo sapiens_hsa05020 | 2.04951131 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00893227 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.97049500 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.95128719 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.86684291 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82673776 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.79381277 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70905721 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.63182266 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56744856 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52099590 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30499525 |
| 26 | Amoebiasis_Homo sapiens_hsa05146 | 1.28220594 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21963566 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21505114 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21259499 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07122656 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05760470 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05562824 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03706235 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98955935 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98503751 |
| 36 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96074288 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 0.93302056 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92912595 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 0.91890470 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90900594 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 0.89624093 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88269298 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 0.87915444 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81988559 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81789264 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77474540 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76993137 |
| 48 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70702925 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.70373212 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67871949 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66882304 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66193657 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65674279 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64693340 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62314682 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59768592 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57670200 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56202554 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56187185 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56143510 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.55429102 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54489018 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53770612 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52331724 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50788222 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50096614 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49330909 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48508551 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.48360717 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47390570 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46937618 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.46735129 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45295559 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.45098115 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44278708 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43638583 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43025890 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42618451 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42459963 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42316649 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41960617 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41586941 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40962980 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.38785671 |
| 85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38607492 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38461426 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38045445 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37977135 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37750024 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37585015 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.37484509 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37397616 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35661056 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35374300 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34887019 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33727613 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.33587994 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33580710 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32980063 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.32886452 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.32676288 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31827546 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.30001780 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29728088 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29518996 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.29160895 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27691476 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.26806973 |
| 109 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26290638 |
| 110 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24412155 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24346840 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.23942436 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22863449 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22770216 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22333624 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22320186 |
| 117 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.22019377 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.21104026 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21043089 |
| 120 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20653151 |
| 121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19863093 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19772319 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.19091577 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18478202 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.17929275 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15097977 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14632886 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14316401 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.13861401 |
| 130 | Influenza A_Homo sapiens_hsa05164 | 0.13479441 |
| 131 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12736717 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12582671 |
| 133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12456525 |
| 134 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.11921460 |
| 135 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.11750179 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.10933929 |

